Management of Elevated Liver Enzymes

Classification and Diagnostic Evaluation

Liver injury is classified based on the ratio (R) of ALT/ALP, with hepatocellular pattern: R ≥5, cholestatic pattern: R ≤2, and mixed pattern: R between 2 and 5 3
Criteria defining significant liver injury include ALT ≥5× upper limit of normal (ULN), ALP ≥2× ULN, and ALT ≥3× ULN with total bilirubin >2× ULN 3, 4
The American Association for the Study of Liver Diseases recommends assessing risk factors for liver disease, including detailed alcohol consumption history and complete medication and supplement review 3, 2
Laboratory testing should include complete liver panel, viral hepatitis serologies, thyroid function tests, and creatine kinase to rule out muscle disorders as cause of AST elevation 2

For hepatocellular pattern, nonalcoholic fatty liver disease (NAFLD) is the most common cause in patients with metabolic risk factors, and lifestyle modifications are recommended 1, 2
For alcoholic liver disease, complete alcohol cessation is recommended, and transaminases should be monitored after abstinence 2
For medication-induced liver injury, suspected hepatotoxic medications should be discontinued when possible, and liver enzymes should be monitored after medication discontinuation 2
For viral hepatitis, referral for specific management based on viral etiology is recommended 2

For mild elevations without identified cause, liver enzymes should be repeated in 2-4 weeks 2
For identified causes, response to specific interventions should be monitored 2
Hepatology referral is considered if transaminases remain elevated for ≥6 months, evidence of synthetic dysfunction is present, ALT increases to >5× ULN, or ALT elevation is accompanied by increase in total bilirubin >2× ULN 2, 3

AST is less specific for liver injury than ALT and can be elevated in cardiac, skeletal muscle, kidney, and red blood cell disorders 2
Isolated increases in GGT are not markers of cellular damage but rather indicate enzyme induction 3, 4